Brief: Universal Biosensors Seeks Trading Halt
17/03/2024 22:04
March 18 (Reuters) - Universal Biosensors Inc UBI.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON RESULTS OF U.S.
FDA
REVIEW OF XPRECIA PRIME COAGULATION SYSTEM
Further company coverage: UBI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Universal Biosensors
See all newsBrief: Universal Biosensors Seeks Trading Halt Pending Announcement On Financial Position & Funding
Brief: Universal Biosensors Signs Non-Binding Term Sheet For A$8.5M Funding
Brief: Universal Biosensors Seeks Trading Halt
Brief: Universal Biosensors Inc Posts Qtrly Total Revenue A$1.6 Million
Brief: Universal Biosensors Says John Sharman Steps Down As Managing Director And CEO